United States · Biotechnology startup
United States · NKT Therapeutics
NKT Therapeutics is a privately held biotechnology company focused on developing therapeutics to treat cancer and other serious diseases.
Funding reportedLast round: Undisclosed round
What company datasets say NKT Therapeutics raised
Funding, as reported
Reported in all$12Min dollars
Rounds3
Last roundUndisclosed round
Last round dateDec 2016
Investors listed2
SEC Form D$4.0M sold, 1 filing, last Aug 2010
Founders and team
From the SEC filings it signed: 2 on the team.
- Alemseged TrunehExecutive Officeri
- Robert MashalExecutive Officer, Director, Promoteri
On the board, as filediDavid J. HungMaggie J. LeFloreMichael J. Ross
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put NKT Therapeutics in front of investors. Or tell us what we have wrong.